Showing results (1-10 of 325) with videos related to
Sort By:
Pageof 33
Circulation|June 1, 1991
Experimental arterial thrombosis in nonhuman primatesL A Harker, A B Kelly, S R HansonThrombosis and Haemostasis|July 1, 1997
Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generationL A Harker, S R Hanson, A B KellyHaemostasis|January 1, 1996
Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathwayL A Harker, S R Hanson, J N Wilcox, et al.The Journal of Laboratory and Clinical Medicine|October 1, 1989
Prevention of heparin-resistant thrombotic occlusion of hollow-fiber hemodialyzers by synthetic antithrombinA B Kelly, S R Hanson, L W Henderson, et al.Circulation|January 15, 1996
Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectorsD A Dichek, J Anderson, A B Kelly, et al.Circulation|October 1, 1991
Reduction in thrombus formation by placement of endovascular stents at endarterectomy sites in baboon carotid arteriesW C Krupski, A Bass, A B Kelly, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1992
Antithrombotic effects of synthetic peptides targeting various functional domains of thrombinA B Kelly, J M Maraganore, P Bourdon, et al.Neurological Research|January 1, 1992
Production of transient ischaemic events by platelet emboli in baboonsC Kessler, A B Kelly, W D Suggs, et al.Circulation|December 1, 1991
Antithrombotic effects of combining activated protein C and urokinase in nonhuman primatesA Gruber, L A Harker, S R Hanson, et al.Arteriosclerosis (Dallas, Tex.)|May 1, 1990
Inhibition of thrombus formation in vivo by novel antiplatelet agentU M Marzec, A B Kelly, S R Hanson, et al.Pageof 33